DataQuest vs ETPharma

Referred to as the Bible of Indian IT, DATAQUEST has constantly endeavored to highlight the major issues faced by the industry and users, publishing in-depth analyses of market trends and fast changing technologies. As the pioneer and leader of IT media in India since 1982, the magazine has consistently kept track of new developments in the IT industry and the corresponding information needs of the corporate user. Magazine Subscriptions are available for purchase inside this app. Three months subscription - $4.99 (automatically renewed until canceled) Six months subscription - $9.99 (automatically renewed until canceled) One year subscription - $18.99 (automatically renewed until canceled) Your subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Your iTunes account will automatically be charged at the same price for renewal within 24-hours prior to the end of the current period unless you change your subscription preferences in your account settings. You can manage your subscriptions through your account settings after purchase on your device. No cancellation of the current subscription is allowed during active subscription period. Please visit http://www.magzter.com/ns/privacy-policy.html for our Privacy Policy and http://www.magzter.com/ns/terms_condition.html for our Terms & Conditions

ETPharma tracks all the media agencies focusing on the Pharma sector and tracks the most relevant and important news and analysis on the industry. Through its features such as Articles, Blogs, Polls and Slideshows, it covers different aspect of the industry in one single platform. ETPharma sends out a free daily newsletter to its subscribers - summarizing day’s essential news, reports and analysis. We link all the stories around the web and track all the top sources, including news sites, reporters, tweets and status updates to bring to our subscribers a comprehensive view of the latest updates in the industry. Daily E-Newsletter Our newsletter attracts a readership of decision makers, policy makers, investors and professionals from the Pharma sector in India.